by The pharmaceutical drug delivery market involves developing delivery systems for drugs and pharmaceutical compounds. Pharmaceutical drugs can be administered using various delivery routes such as oral, pulmonary, transdermal, injectable and others. Oral drug delivery is the most common and preferred route owing to ease of administration and patient compliance. However, drugs may be unstable in the gastrointestinal tract or have poor membrane permeability for absorption. To overcome these challenges, novel site-specific drug delivery systems are being developed using materials such as polymers, lipids and carbohydrates. Polymer-based drug deliverysystems such as hydrogels help modify the drug’s release kinetics and sustain therapeutic levels. Liposomes are actively researched as carriers for hydrophobic drugs to improve their bioavailability.
The global Pharmaceutical Drug Delivery Market is estimated to be valued at US$ 2657.98 Bn in 2024 and is expected to exhibit a CAGR of 13.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends in the Global Pharmaceutical Drug Delivery Market Size industry is the rise of personalized medicine. With advances in pharmacogenomics and companion diagnostics, treatments can be customized based on a person’s genetic makeup and disease characteristics. This allows selection of the most appropriate drug and delivery system for an individual. 3D printing is also gaining popularity for fabrication of customized drug products with specific release profiles or forms like implants. It allows incorporation of multiple drugs into a single dosage form for personalized combination therapies.
Porter’s Analysis
Threat of new entrants: The threat is moderate due to high capital requirements, regulatory barriers and established brands of existing players.
Bargaining power of buyers: The bargaining power is high due to presence of many players and differentiated products. Buyers can negotiate on price and demand value-added services.
Bargaining power of suppliers: The power of suppliers is moderate as there are many suppliers for raw materials and consumables required in pharmaceutical drug delivery.
Threat of new substitutes: The threat is low as there are limited alternatives for drug delivery due to stringent regulatory norms.
Competitive rivalry: The rivalry is high due to presence of many global and local players offering differentiated products. Players compete based on pricing, innovation, service and brand.
Key Takeaways
The global pharmaceutical drug delivery market is expected to witness high growth over the forecast period.
Regional analysis: North America is the largest and fastest growing regional market for pharmaceutical drug delivery attributed to developed healthcare infrastructure, high healthcare spending and presence of leading players in USA and Canada. Europe is another major regional market driven by rising research activities and increasing focus on drug delivery technologies by players in the region.
Key players: Key players operating in the pharmaceutical drug delivery market are Thermo Fisher Scientific Inc., Corning Incorporated, Lonza Group Ltd., Avantor, Inc., Synthecon Incorporated, Bico Group, ReproCELL Incorporated, Becton, Dickinson, and Company, 3D Biotek, LLC, InSphero AG. Thermo Fisher Scientific Inc. and Corning Incorporated are the leading players in the market offering integrated solutions for drug delivery applications.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
